CR
CHARLES RIVER LABORATORIES
CRL· Health Care· Life Sciences Tools & ServicesS&P 500
Close · 13/11/2026
337.97
1D
-0.83%52-week range
146.2 – 379.63
Volume
8,38,300.00
Price history
CRL
15/10/2026 to 13/11/2026
O 342.18 H 342.58 L 333.04
1W+0.13%
1M+10.36%
3M+17.91%
6M+124.04%
1Y+97.07%
3Y+92.06%
5Y-9.93%
MAX-21.62%
Fundamentals
as of 13/11/2026- Market cap
- $16.19B
- Shares out
- 47.92M
- P/E (trailing)
- 402.98
- P/E (forward)
- 26.06
- EPS (trailing)
- 0.84
- Dividend yield
- 0.00%
- Beta
- 1.34
- Profit margin
- 1.01%
- P/B
- 5.02
- Return on equity
- 1.25%
SEC financial statements
61 quarterly and 18 annual periods through 26/09/2026.
Details
- Ticker
- CRL
- Index
- SP500
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
5 filers · 0 on watchlist · 4 buys · 4 sells · D: 4 · R: 4
- 12/05/2025Jefferson ShreveSellCharles River Laboratories International, Inc. Common Stock$15,001–$50,000
- 08/05/2025Jefferson ShreveBuyCharles River Laboratories International, Inc. Common Stock$15,001–$50,000
- 15/05/2025Rob BresnahanSellCharles River Laboratories International, Inc. Common Stock$1,001–$15,000
- 08/04/2025Rob BresnahanBuyCharles River Laboratories International, Inc. Common Stock$15,001–$50,000
- 15/01/2025Julie JohnsonBuyCharles River Laboratories International, Inc. Common Stock$1,001–$15,000
- 08/09/2023Lois FrankelSellCharles River Laboratories International, Inc.$1,001–$15,000
- 25/04/2023Lois FrankelBuyCharles River Laboratories International, Inc.$1,001–$15,000
- 25/08/2022Zoe LofgrenSellCharles River Laboratories International, Inc.$1,001–$15,000